![](/img/cover-not-exists.png)
297 Chemoimmunotherapy with weekly cisplatin and etoposide plus S.C. rIL-2 plus oral medroxyprogesterone acetate (MPA) in stage IIIB-IV NSCLC: Preliminary results on clinical response and on immunologic assessment
Mantovani, G., Macciò, A., Lai, P., Esu, S., Massa, E., Ghiani, M., Astara, G., Manca, G., Massa, D., Lampis, B., Succu, G., Pisano, M., Versace, R., Pusceddu, G.Volume:
18
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(97)89677-8
Date:
August, 1997
File:
PDF, 144 KB
english, 1997